LIBERVANT
Live / Registered — Registered (as of 10 Sept 2024)
What this means for you
Registered since 10 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90309531
- Registration number
- 7502636
- Mark type
- Stylized text
- Filed
- 10 Nov 2020
- Published for opposition
- 27 Apr 2021
- Registered
- 10 Sept 2024
- Attorney of record
- Carrie Webb Olson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, inflammatory, pain, respiratory, hormonal, central nervous system, and psychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of epilepsy, anxiety disorders, seizure disorders, sleep disorders, insomnia, alcohol, opiate and benzodiazepine withdrawal syndrome, muscle spasms, and psychiatric disorders; pharmaceutical preparations, namely, anticonvulsants, antiseizure medications, psychotropics, benzodiazepines, sedatives, muscle relaxants, and mood stabilizing medications
Owner
- Aquestive Therapeutics, Inc., Warren, NJ, US
- Aquestive Therapeutics, Inc., Warren, NJ, US
- Aquestive Therapeutics, Inc., Warren, NJ, US
Prosecution history
- 10 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 08 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Aug 2024 — ASSIGNED TO EXAMINER
- 26 Jul 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 26 Jul 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Jul 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Jul 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Jun 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Jun 2024 — USE AMENDMENT FILED
- 18 Jun 2024 — TEAS STATEMENT OF USE RECEIVED
- 28 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Nov 2023 — SOU EXTENSION 5 GRANTED
- 13 Nov 2023 — SOU EXTENSION 5 FILED